Hypofractionated Adjuvant Radiotherapy for Resected Head and Neck Cancers

NCT05120947 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Resectable Head and Neck Squamous Cell Carcinoma

Interventions

RADIATION: 42 Gy Radiation Therapy
RADIATION: 39 Gy Radiation Therapy
RADIATION: 32.5 Gy Radiation Therapy

Sponsor

Medical College of Wisconsin